Expression of multidrug resistance gene and DNA ploidy in locally advanced gastric and gastroesophageal junction adenocarcinoma

被引：0
|
作者：
Biswas, A. [1 ]
Mohanti, B. K. [1 ]
Das, S. N. [1 ]
Rath, G. K. [1 ]
Sharma, A. [1 ]
Raina, V. [1 ]
Deo, S. N. [1 ]
Shukla, N. K. [1 ]
Thulkar, S. [1 ]
Gupta, S. Datta [1 ]
机构：
[1] All India Inst Med Sci, Delhi, India
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70994-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
187
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [1] Study to evaluate response to preoperative chemotherapy followed by postoperative chemoradiotherapy, expression of multidrug resistance gene and quality of life in locally-advanced gastric and gastroesophageal junction adenocarcinoma
    Biswas, A.
    Mohanti, B. K.
    Rath, G. K.
    Sharma, A.
    Raina, V.
    Deo, S. V.
    Shukla, N. K.
    Thulkar, S.
    Gupta, S. Datta
    Das, S. N.
    EJC SUPPLEMENTS, 2009, 7 (02): : 369 - 369
  • [2] Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
    Liu, Xiao
    Ma, Baozhen
    Zhao, Lingdi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [3] Biomarkers of neoadjuvant combinational therapy for locally advanced gastric or gastroesophageal junction adenocarcinoma
    Wang, Y.
    Yang, J.
    Zhou, X.
    Liu, Q.
    Yang, Y.
    Guan, W.
    Liu, B.
    Wei, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S245 - S245
  • [4] Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma
    Joshi, Smita S.
    Maron, Steven B.
    Catenacci, Daniel V.
    FUTURE ONCOLOGY, 2018, 14 (05) : 417 - 430
  • [5] Phase II study of perioperative camrelizumab and XELOX for locally advanced gastric or gastroesophageal junction adenocarcinoma
    He, Jiaxing
    Zhang, Bo
    Zhou, Shuai
    Yang, Ying
    Han, Zhuo
    Wu, Tao
    Qiao, Qing
    Yang, Haicheng
    He, Xianli
    Wang, Nan
    CANCER SCIENCE, 2024,
  • [6] TARGETED LYMPHADENECTOMY IN PATIENTS WITH LOCALLY ADVANCED GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
    Lukavetskyy, N.
    Fetsych, T.
    Bilynsky, T.
    Gnativ, I
    Hipp, I
    Vovk, I
    ANNALS OF ONCOLOGY, 2009, 20 : 82 - 82
  • [7] Therapy for Locally Advanced Adenocarcinoma of the Gastroesophageal Junction: Optimizing Outcome
    Kleinberg, Lawrence
    SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (01) : 38 - 50
  • [8] Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
    Peng, Zhi
    Li, Zhongwu
    Gao, Jing
    Lu, Ming
    Gong, Jifang
    Tang, En-Tzu
    Oliner, Kelly S.
    Hei, Yong-Jiang
    Zhou, Hui
    Shen, Lin
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (11) : 2634 - 2641
  • [9] Camrelizumab combined with FOLFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Liu, Ying
    Han, Guangsen
    Li, Hongle
    Zhao, Yuzhou
    Zhuang, Jing
    Wang, Gangcheng
    Li, Baodong
    Wang, Jinbang
    Li, Zhimeng
    Xia, Qingxin
    Ma, Jie
    Zhang, Chengjuan
    Yu, Juan
    Li, Ke
    Xu, Shuning
    Qiao, Lei
    Kuang, Gaizhen
    Li, Danyang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Perioperative sintilimab in combination with concurrent chemoradiotherapy for patients with locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Wei, J.
    Lu, X.
    Liu, Q.
    Li, L.
    Liu, S.
    Liu, F.
    Fu, Y.
    Fan, X.
    Yang, J.
    Yang, Y.
    Zhao, Y.
    Guan, W.
    Liu, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S1316 - S1316
12345